Scientists awarded $7.7 million grant to develop treatment for rare brain disorder

Children born with a damaged gene needed for healthy brain development, SYNGAP1, experience seizures, sensory processing disorders, difficulty speaking, intellectual disability, and autism-like behaviors.

Compounded semaglutide is an ill-defined public health crisis

I first met Jane (not her real name, of course) on a Friday afternoon in our clinic. She was referred for further evaluation of her

September 13, 2024

Study examines the benefit of adding yoga therapy as a complementary treatment for heart failure

Previous studies have shown that yoga therapy and lifestyle modifications have improved heart failure patients’ quality of life and enhanced their cardiovascular function.

September 26, 2023

Nanobody technology revolutionizes food allergy detection methods

Recent advancements show nanobodies from camelid antibodies excel in food allergen detection with superior stability, specificity, and cost-effectiveness. This innovative approach aims to improve accuracy

June 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.